Skip to content
Around 100 clinical trials are currently in progress, will these new studies and drug development pave the way for psychedelics to be used as accepted medical treatments?

Details

  • Main Stage
Date:
11/05/2022
Start Time:
9:00 am
End Time:
09:45

Dr. Amy Reichelt

Chief Innovation Officer, PurMinds Neuropharma

Dr. Amy Reichelt is a recognized leader in neuroscience, specializing in psychedelic drug development. She has 15 years of expertise in translational medicine spanning from molecules to mind, and is p…

Dr. Steve Levine, MD

Senior Vice President, Patient Access & Medical Affairs for COMPASS Pathways; co-founder and Chairman of Heading Health, Compass Pathways

Dr. Steve Levine is a board-certified psychiatrist internationally recognized for his contributions to advancements in mental health care, particularly the development of care models to deliver ketami…

Dr. Rishi Kakar, MD

Chief Medical Scientist, Segal Trials

Dr. Kakar is the Chief Scientific Officer and Medical Director for Segal Trials, located in South Florida. In addition, he is the Director of Segal’s Center for Psychedelic Research division, where he…

Justin Hanka

Co-Founder & Director, MindBio Therapeutics

Justin Hanka (Co-Founder & Director) is an investment banker with expertise in M&A and capital markets transactions in Australia, Europe and North America.

Andrew Charrette

VP of Regulatory Affairs, Wellbeing Digital Sciences

Leading Regulatory Affairs at Wellbeing Digital Sciences, as well as Regulatory Affairs and Psychedelic Research at KGK Science, Andrew Charrette brings extensive experience in clinical research and i…

Dr. Christopher Bryan, Ph.D.

Vice President Research and Operations, Algernon Pharmaceuticals

Dr. Christopher Bryan graduated from the University of Toronto, with a Ph.D. in organic chemistry and brings significant skills and experience to Algernon. His background as a scientist and senior man…

Get Recordings Now!

Easily access the recordings for your favorite Wonderland sessions, allowing you to revisit the discussions and insights shared by our visionary speakers.

Buy Now